AI Drug Discovery Startups: Analysis Of Exscientia’s Acquisition By Recursion

Exscientia is a European player looking to make a difference in the AI-drug discovery market. Like other players, it has an interesting story to tell. After a brief listing on the stock market, Exscientia was acquired by another firm last year.